Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
---|---|---|---|---|---|---|
Q3 2024 | 124 | 158,217 | MSFT, AAPL, COST, ORCL | 13F-HR | 11/13/2024 | 000163177524000005 |
Q2 2024 | 119 | 149,981 | MSFT, AAPL, COST, INTU | 13F-HR | 8/12/2024 | 000163177524000003 |
Q1 2024 | 121 | 148,815 | MSFT, AAPL, INTU, COST | 13F-HR | 5/15/2024 | 000163177524000002 |
Q4 2023 | 117 | 139,200 | MSFT, AAPL, INTU, COST | 13F-HR | 2/12/2024 | 000163177524000001 |
Q3 2023 | 114 | 132,454 | MSFT, AAPL, INTU, COST | 13F-HR | 11/13/2023 | 000163177523000004 |
Q2 2023 | 116 | 145,219 | MSFT, AAPL, GMED, INTU | 13F-HR | 8/14/2023 | 000163177523000003 |
Q1 2023 | 118 | 141,649 | MSFT, AAPL, INTU, GMED | 13F-HR | 5/12/2023 | 000163177523000002 |
Q4 2022 | 113 | 137,092 | MSFT, AAPL, GMED, INTU | 13F-HR | 2/13/2023 | 000163177523000001 |
Q3 2022 | 117 | 135,443 | MSFT, AAPL, GMED, INTU | 13F-HR | 11/14/2022 | 000163177522000004 |
Q2 2022 | 115 | 139,249 | MSFT, AAPL, GMED, COST | 13F-HR | 8/10/2022 | 000163177522000003 |
Q1 2022 | 115 | 162,738 | MSFT, AAPL, GMED, INTU | 13F-HR | 5/12/2022 | 000163177522000002 |
Q4 2021 | 118 | 175,659 | MSFT, AAPL, INTU, GMED | 13F-HR | 2/14/2022 | 000163177522000001 |
Q3 2021 | 114 | 160,401 | MSFT, AAPL, INTU, GMED | 13F-HR | 11/12/2021 | 000163177521000004 |
Q2 2021 | 117 | 161,428 | MSFT, AAPL, GMED, INTU | 13F-HR | 8/9/2021 | 000163177521000003 |
Q1 2021 | 114 | 143,508 | MSFT, AAPL, GMED, INTU | 13F-HR | 5/12/2021 | 000163177521000002 |
Q4 2020 | 111 | 135,639 | MSFT, AAPL, GMED, INTU | 13F-HR | 2/8/2021 | 000163177521000001 |
Q3 2020 | 105 | 118,524 | MSFT, AAPL, GMED, INTU | 13F-HR | 11/12/2020 | 000163177520000004 |
Q2 2020 | 99 | 106,754 | MSFT, AAPL, GMED, INTU | 13F-HR | 8/11/2020 | 000163177520000003 |
Q1 2020 | 96 | 91,994 | MSFT, AAPL, GMED, INTU | 13F-HR | 5/6/2020 | 000163177520000002 |
Q4 2019 | 112 | 121,355 | MSFT, GMED, AAPL, INTU | 13F-HR | 2/10/2020 | 000163177520000001 |
Q3 2019 | 109 | 113,134 | MSFT, GMED, AAPL, INTU | 13F-HR | 11/12/2019 | 000163177519000004 |
Q2 2019 | 107 | 108,197 | MSFT, GMED, INTU, AAPL | 13F-HR | 8/9/2019 | 000163177519000003 |
Q1 2019 | 104 | 104,083 | MSFT, GMED, INTU, AAPL | 13F-HR | 5/9/2019 | 000163177519000002 |
Q4 2018 | 100 | 89,401 | MSFT, GMED, BRK-B, INTU | 13F-HR | 2/12/2019 | 000163177519000001 |
Q3 2018 | 110 | 102,763 | GMED, MSFT, AAPL, INTU | 13F-HR | 11/9/2018 | 000163177518000004 |
Q2 2018 | 109 | 95,547 | MSFT, GMED, AAPL, INTU | 13F-HR | 8/10/2018 | 000163177518000003 |
Q1 2018 | 108 | 92,750 | MSFT, GMED, BRK-B, AAPL | 13F-HR | 5/10/2018 | 000163177518000002 |
Q4 2017 | 122 | 98,805 | MSFT, GMED, BRK-B, AAPL | 13F-HR | 2/13/2018 | 000163177518000001 |
Q3 2017 | 129 | 99,612 | MSFT, AAPL, BRK-B, PGX | 13F-HR | 11/9/2017 | 000163177517000004 |
Q2 2017 | 127 | 100,769 | MSFT, AAPL, BRK-B, GMED | 13F-HR | 8/14/2017 | 000163177517000003 |
Q1 2017 | 132 | 101,828 | MSFT, AAPL, BRK-B, PGX | 13F-HR | 5/11/2017 | 000163177517000002 |
Q4 2016 | 131 | 97,741 | MSFT, BRK-B, IWM, PGX | 13F-HR | 2/15/2017 | 000163177517000001 |
Q3 2016 | 134 | 96,836 | MSFT, PGX, JNJ, IWM | 13F-HR | 11/14/2016 | 000163177516000008 |
Q2 2016 | 128 | 94,886 | MSFT, PGX, JNJ, BRK-B | 13F-HR | 8/12/2016 | 000163177516000007 |
Q1 2016 | 135 | 96,535 | MSFT, PGX, BRK-B, GMED | 13F-HR | 5/13/2016 | 000163177516000006 |
Q4 2015 | 137 | 95,882 | MSFT, GMED, PGX, BRK-B | 13F-HR | 2/16/2016 | 000163177516000005 |
Q3 2015 | 140 | 91,309 | PGX, MSFT, AAPL, BRK-B | 13F-HR | 11/12/2015 | 000163177515000004 |
Q2 2015 | 140 | 98,422 | PGX, MSFT, GMED, IWM | 13F-HR | 8/12/2015 | 000163177515000003 |
Q1 2015 | 135 | 97,743 | PGX, AAPL, GMED, BRK-B | 13F-HR | 5/12/2015 | 000163177515000002 |
Q4 2014 | 287 | 109,835 | MSFT, PGX, BRK-B, GMED | 13F-HR | 2/6/2015 | 000163177515000001 |